Could a simple phlegm test quiet the debilitating cough of lung disease?
NCT ID NCT05086432
Summary
This study is testing if analyzing a patient's phlegm (sputum) helps doctors choose more effective treatments to reduce chronic cough in people with interstitial lung disease (ILD). About 120 adults with ILD and a daily cough will be randomly assigned to either receive treatment based on their phlegm test results or receive standard care. The goal is to see if this personalized approach improves cough frequency and quality of life over 16 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ILD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Joseph's Healthcare Hamilton
RECRUITINGHamilton, Ontario, L8N 4A6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.